Geron (GERN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GERN Geron

Watchlist

4.020
+0.030+0.75%

Close Nov 21 16:00 ET

4.020
0.0000.00%

Post 16:55 ET

2.43BMarket Cap-12562P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Reuters29minutes ago
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Businesswire29minutes ago
Express News | Geron Corporation Announces Appointment of Joseph Eid, M.d. as Executive Vice President, Research and Development
ReutersNov 11 16:30 ET
Geron to Participate in the Stifel 2024 Healthcare Conference
BusinesswireNov 11 09:00 ET
TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsNov 11 08:37 ET · Ratings
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results
Yahoo FinanceNov 10 08:56 ET

Comments

Tonyco

Nov 17 17:09

$Geron (GERN.US)$
Almost low enough

Trytosaveabit

Nov 7 06:27

A bit more

$Geron (GERN.US)$ Reuters· 2 mins ago
Geron Corp - Receives $250 Million at Closing, $125 Million in Debt Available

Trytosaveabit

Nov 7 06:13

News

$Geron (GERN.US)$ Reuters· 1 mins ago
Royalty Pharma to Acquire Royalty Interest in Geron’s Rytelo for $125 Million

Trytosaveabit

Nov 7 06:05

Some

$Geron (GERN.US)$ Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Achieved $28.2 million in RYTELO(TM) (imetelstat) net product revenue in first full quarter of sales
Received $250 million in gross proceeds from synthetic royalty and debt financings with Royalty Pharma and Pharmakon Advisors, with access to an additional $125 million in debt

Trytosaveabit

Nov 7 06:05

$Geron (GERN.US)$ 🤔

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

GERN Geron

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target